Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1424.8000 19.10 (1.36%)
NSE Dec 19, 2025 15:31 PM
Volume: 169.8K
 

1424.80
1.36%
Prabhudas Lilladhar
EPS increased by 33%/2% for FY21/22E while 6% decreased for FY23E. 1QFY21 earnings was much higher than our estimate due to 1) incremental revenue of Rs2.59bn related to HCQS and CQ supply 2) better gross margin...
Ipca Laboratories Ltd. is trading above all available SMAs
More from Ipca Laboratories Ltd.
Recommended